Thrombolytic therapy: reocclusion rates with adjunctive aspirin and its relation to heparin therapy.
Sherry
S
S
Marder
V J
VJ
D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003328:Coronary Thrombosis / Q000453:epidemiology / Q000628:therapy*; D006493:Heparin / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D012008:Recurrence; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D016896:Treatment Outcome; D014654:Vascular Patency / Q000187:drug effects
D006493:Heparin; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D001241:Aspirin